1 | 5 ASA, enemas, suppositories, corticosteroids | - | - | - | - | [1] 97 97 |
2 | ACEI/ARB and corticosteroids | - | - | - | - | [1] 66 66 |
3 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 85 85 |
4 | Corticosteroids | - | - | - | - | [12] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 |
5 | Corticosteroids & tanCART19/20 | - | - | - | - | [1] 13 13 |
6 | Corticosteroids (Aprednislon) | - | - | - | - | [1] 63 63 |
7 | Corticosteroids (prednisone or prednisolone) | [2] Prednisolone Prednisolone, Prednisone | [2] D00472
D00472
,
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 |
8 | Corticosteroids +immune suppressive +amino salicylic acid | [1] Salicylic acid Salicylic acid | [1] D00097
D00097
| - | - | [1] 97 97 |
9 | Corticosteroids for Systemic Use | - | - | - | - | [1] 41 41 |
10 | Corticosteroids only | - | - | - | - | [1] 97 97 |
11 | Corticosteroids'therapy | - | - | - | - | [1] 35 35 |
12 | CS (corticosteroids) Only | - | - | - | - | [1] 97 97 |
13 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | [2] Mesalazine Mesalazine, Methylprednisolone | [2] D00377
D00377
,
D00407
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
14 | Oral corticosteroids | - | - | - | - | [5] 13 13, 46, 97, 171, 251 |
15 | Oral corticosteroids (OCS) | - | - | - | - | [1] 162 162 |
16 | Rituximab, Cyclophosphamide, and Corticosteroids | [2] Cyclophosphamide Cyclophosphamide, Rituximab | [3] D00287
D00287
,
D02994
,
D07760
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 222 222 |
17 | Valproid acid plus corticosteroids | - | - | - | - | [1] 26 26 |